Latest Period
Q4 2025
CUSIP: 86889P208
Latest Period
Q4 2025
Institutions Reporting
53
Shares (Excl. Options)
6,756,528
Price
$22.60
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.
Latest holder context comes from 53 institutions filings for Q4 2025.
What is CUSIP 86889P208?
CUSIP 86889P208 identifies SRZN - Surrozen, Inc./DE - Common Stock, par value $0.0001 per share in SEC 13F datasets.
Where can I see the latest institutional holders?
Review the Q4 2025 holders report and the ownership history table below.
Use the next link that matches the question you still need to answer about this security.
Open recent reporting periods for CUSIP 86889P208:
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| Column Group IV GP, LP | 12% | $131,204,153 | 6,353,712 | Tim Kutzkey | 06 Feb 2026 | |||
| COLUMN GROUP III GP, LP | 35% | +3.2% | $82,420,389 | +$8,990,811 | 3,824,612 | +12% | Tim Kutzkey | 20 Jan 2026 |
| TCG Crossover GP II, LLC | 11% | $27,454,916 | 1,274,010 | Chen Yu | 26 Jan 2026 | |||
| 5AM Partners VII, LLC | 9.9% | $9,102,038 | 908,387 | 5AM Partners VII, LLC | 26 Mar 2025 | |||
| Venrock Healthcare Capital Partners III, L.P. | 9.9% | $8,742,911 | 872,546 | Venrock Healthcare Capital Partners III, L.P. | 26 Mar 2025 | |||
| RA CAPITAL MANAGEMENT, L.P. | 9.2% | -7% | $18,001,245 | +$89,063 | 871,731 | +0.5% | RA Capital Management, L.P. | 31 Dec 2025 |
| AI Biotechnology LLC | 9.9% | $8,462,521 | 844,563 | AI Biotechnology LLC | 24 Mar 2025 | |||
| INTEGRATED CORE STRATEGIES (US) LLC | 8.5% | +27% | $15,649,459 | +$3,477,006 | 726,193 | +29% | Millennium Management LLC | 31 Dec 2025 |
| STEMPOINT CAPITAL LP | 7% | -40% | $12,798,168 | -$8,186,300 | 619,766 | -39% | StemPoint Capital LP | 31 Dec 2025 |
| Point72 Asset Management, L.P. | 5.4% | $16,908,020 | 615,957 | Point72 Asset Management, L.P. | 22 Apr 2026 | |||
| BRAIDWELL LP | 5.5% | $9,705,500 | 470,000 | BRAIDWELL LP | 31 Dec 2025 | |||
| Nantahala Capital Management, LLC | 5.2% | -48% | $4,011,184 | +$1,025,211 | 455,299 | +34% | Nantahala Capital Management, LLC | 30 Jun 2025 |
| Stonepine Capital Management, LLC | 3.6% | -37% | $6,531,368 | -$3,973,019 | 316,289 | -38% | Stonepine Capital Management, LLC | 31 Dec 2025 |
| PERCEPTIVE ADVISORS LLC | 1.9% | -64% | $1,669,993 | 166,666 | 0% | Perceptive Advisors LLC | 31 Mar 2025 | |
| REGENTS OF THE UNIVERSITY OF CALIFORNIA | 4.2% | $1,334,734 | 133,207 | REGENTS OF THE UNIVERSITY OF CALIFORNIA | 31 Dec 2024 | |||
| Nantahala Capital Partners Limited Partnership | 2.2% | -62% | $740,658 | -$1,032,581 | 73,918 | -58% | NANTAHALA CAPITAL PARTNERS LIMITED PARTNERSHIP | 31 Mar 2025 |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 0.79% | -91% | $595,256 | -$1,210,212 | 67,566 | -67% | DRIEHAUS CAPITAL MANAGEMENT LLC | 30 Jun 2025 |
| Alyeska Investment Group, L.P. | 0.8% | $269,087 | 26,855 | Alyeska Investment Group, L.P. | 31 Dec 2024 |
As of 31 Dec 2025, 53 institutional investors reported holding 6,756,528 shares of Surrozen, Inc./DE - Common Stock, par value $0.0001 per share (SRZN). This represents 59% of the company’s total 11,406,611 outstanding shares.
The largest institutional shareholders of Surrozen, Inc./DE - Common Stock, par value $0.0001 per share (SRZN) together control 55% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| MILLENNIUM MANAGEMENT LLC | 6.3% | 721,266 | +557% | 0.01% | $16,300,612 |
| VR ADVISER, LLC | 5.5% | 632,931 | 0% | 0.71% | $14,304,241 |
| STEMPOINT CAPITAL LP | 5.4% | 619,766 | -13% | 2.2% | $12,672,108 |
| BRAIDWELL LP | 4.1% | 470,000 | +236% | 0.34% | $10,622,000 |
| Spruce Street Capital LP | 3.8% | 432,040 | 0% | 3.2% | $9,764,104 |
| Boxer Capital Management, LLC | 3.6% | 416,150 | 2.1% | $9,404,990 | |
| 5AM Venture Management, LLC | 3.4% | 387,500 | +25% | 2.8% | $8,757,500 |
| VANGUARD GROUP INC | 2.8% | 319,236 | +20% | 0% | $7,214,734 |
| Vivo Capital, LLC | 2.3% | 260,000 | 0% | 0.38% | $5,876,000 |
| Woodline Partners LP | 2% | 230,572 | +378% | 0.02% | $5,210,927 |
| Nantahala Capital Management, LLC | 2% | 229,527 | 0% | 0.31% | $5,187,310 |
| Balyasny Asset Management L.P. | 1.7% | 190,489 | +169% | 0.01% | $4,305,051 |
| ACUTA CAPITAL PARTNERS, LLC | 1.6% | 178,415 | 0% | 2.7% | $4,032,179 |
| SILVERARC CAPITAL MANAGEMENT, LLC | 1.4% | 157,323 | 0.51% | $3,555,500 | |
| REGENTS OF THE UNIVERSITY OF CALIFORNIA | 1.2% | 133,207 | 0% | 0.14% | $3,010,478 |
| Stonepine Capital Management, LLC | 1% | 113,631 | -55% | 2% | $2,568,061 |
| Empery Asset Management, LP | 0.91% | 103,974 | 0% | 2.1% | $2,349,812 |
| FRED ALGER MANAGEMENT, LLC | 0.87% | 99,560 | 0.01% | $2,250,056 | |
| Eversept Partners, LP | 0.84% | 95,286 | +24% | 0.12% | $2,153,464 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 0.78% | 88,653 | 0% | 0% | $2,003,558 |
| Euclidean Capital LLC | 0.77% | 87,696 | 0% | 0.54% | $1,981,930 |
| Schonfeld Strategic Advisors LLC | 0.65% | 74,645 | +8.1% | 0.01% | $1,686,975 |
| GEODE CAPITAL MANAGEMENT, LLC | 0.59% | 66,995 | +23% | 0% | $1,514,667 |
| Ikarian Capital, LLC | 0.58% | 65,788 | 0.19% | $1,486,809 | |
| AMERIPRISE FINANCIAL INC | 0.58% | 65,688 | 0% | $1,484,548 |
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2026 Q1 | 2,500 | $72,825 | +$29,130 | $29.13 | 1 |
| 2025 Q4 | 6,756,528 | $151,363,201 | +$40,461,119 | $22.60 | 53 |
| 2025 Q3 | 4,842,546 | $62,396,754 | +$4,541,384 | $12.88 | 35 |
| 2025 Q2 | 4,529,305 | $40,492,894 | +$5,077,667 | $8.94 | 30 |
| 2025 Q1 | 3,947,648 | $46,030,442 | +$26,477,442 | $11.66 | 29 |
| 2024 Q4 | 1,659,393 | $23,812,762 | +$4,279,857 | $14.35 | 23 |
| 2024 Q3 | 1,320,575 | $15,778,814 | +$697,817 | $11.98 | 21 |
| 2024 Q2 | 1,295,142 | $14,182,156 | +$10,447,773 | $10.95 | 20 |
| 2024 Q1 | 340,744 | $5,311,748 | -$371,457 | $15.71 | 15 |
| 2023 Q4 | 412,333 | $3,882,519 | +$3,882,519 | $9.40 | 16 |